DrugPatentWatch Database Preview
Ascent Pharms Inc Company Profile
What is the competitive landscape for ASCENT PHARMS INC, and what generic and branded alternatives to ASCENT PHARMS INC drugs are available?
ASCENT PHARMS INC has fifteen approved drugs.
Summary for Ascent Pharms Inc
| US Patents: | 0 |
| Tradenames: | 11 |
| Ingredients: | 11 |
| NDAs: | 15 |
Drugs and US Patents for Ascent Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ascent Pharms Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 211009-003 | Sep 3, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Ascent Pharms Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, CHEWABLE;ORAL | 210354-003 | Dec 29, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Ascent Pharms Inc | HYDROMORPHONE HYDROCHLORIDE | hydromorphone hydrochloride | SOLUTION;ORAL | 210176-001 | Oct 27, 2017 | AA | RX | No | No | Start Trial | Start Trial | ||||
| Ascent Pharms Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, CHEWABLE;ORAL | 210354-001 | Dec 29, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
